Patents by Inventor Wan Gi Kim

Wan Gi Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240154197
    Abstract: In a method for recovering an active metal of a lithium secondary battery, positive electrode active material particles including a lithium-transition metal oxide is prepared. The positive active material particles are treated by reduction. The reduction-treated positive active particles are subjected to ultrasonic dispersion and hydration. The hydrated transition metal slurry is recovered. The recovery rate of lithium and transition metal can be increased by disaggregation through ultrasonic dispersion.
    Type: Application
    Filed: December 15, 2021
    Publication date: May 9, 2024
    Inventors: Hyeon Bae HA, Hyeon Jung KIM, Sang Ki KIM, Wan Gi KIM
  • Patent number: 11975037
    Abstract: The present specification relates to a composition for preventing, alleviating or treating burnout syndrome, containing a natural extract as an active ingredient. According to one aspect of the present invention, the composition contains a ginseng fruit extract, and thus is useful for preventing, treating and alleviating burnout syndrome. In addition, according to one aspect of the present invention, the composition further contains ginseng fruit and one or more selected from the group consisting of red ginseng, Angelica gigas, Cornus officinalis, Cervi parvum corni, and Nigella sativa, so as to maximize the synergistic effect among two or more ingredients, thereby exhibiting excellent effects on the prevention, treatment and alleviation of burnout syndrome. Therefore, there is an advantage of making individuals and society mentally and physically healthy since burnout syndrome can be prevented, treated and alleviated, by using the composition of the present invention.
    Type: Grant
    Filed: February 5, 2016
    Date of Patent: May 7, 2024
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Su-Hwan Kim, Chan-Woong Park, Sun Mi Kim, Juewon Kim, Byung Gyu Kim, Wan Gi Kim, Sang Jun Lee
  • Patent number: 11096921
    Abstract: The present invention relates to a compound of Formula 1, and an SIRT 1 activator including, as an active ingredient, derivatives thereof or pharmaceutically acceptable salts thereof. The present invention also relates to a composition including the SIRT 1 activator for detoxification, for the improvement of metabolic disorders, for the prevention or improvement of eye diseases, or the prevention or improvement of immune diseases.
    Type: Grant
    Filed: May 20, 2016
    Date of Patent: August 24, 2021
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Byung Gyu Kim, Hyun Woo Jeong, Su Kyung Kim, Si Young Cho, Chan Woong Park, Dae Bang Seo, Wan Gi Kim, Sang Jun Lee
  • Patent number: 10912809
    Abstract: The present invention relates to an enhancer for catechin uptake enhancer in enterocytes, wherein, by mixing a green tea extract containing catechin as an active ingredient, a Dendropanax morbifera extract, and an onion extract at a proper ratio, the stability in the digestive organ can be improved and, eventually, the catechin uptake in enterocytes can be enhanced.
    Type: Grant
    Filed: November 21, 2017
    Date of Patent: February 9, 2021
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Su Kyung Kim, Jin Oh Chung, Wan Gi Kim, Jeong Kee Kim, Song Seok Shin, Soon Mi Shim, Da Yeon Lee, Sang Ryun Yim, Eun Hye Choi
  • Patent number: 10555983
    Abstract: Provided in the present specification is a composition for brain activation, comprising ginseng fruit extract as an active ingredient. The composition according to the present specification allows an increase in blood flow in the brain and thus has an effect of ameliorating chronic fatigue syndrome. In addition, the composition according to the present specification activates the brain, and as a result, strengthens connectivity strength between the frontal lobe and the occipital lobe and thus has an effect of improving problem-solving accuracy and reducing solving time in the area of cognitive ability. Therefore, the composition according to the present specification can be used as a pharmaceutical composition or a food composition for patients suffering from chronic fatigue syndrome.
    Type: Grant
    Filed: March 27, 2014
    Date of Patent: February 11, 2020
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Hyun Jung Shin, Chan Woong Park, Su Hwan Kim, Dae Bang Seo, Wan Gi Kim, Sang Jun Lee
  • Publication number: 20200016224
    Abstract: The present invention relates to an enhancer for catechin uptake enhancer in enterocytes, wherein, by mixing a green tea extract containing catechin as an active ingredient, a Dendropanax morbifera extract, and an onion extract at a proper ratio, the stability in the digestive organ can be improved and, eventually, the catechin uptake in enterocytes can be enhanced.
    Type: Application
    Filed: November 21, 2017
    Publication date: January 16, 2020
    Applicant: AMOREPACIFIC CORPORATION
    Inventors: Su Kyung KIM, Jin Oh CHUNG, Wan Gi KIM, Jeong Kee KIM, Song Seok SHIN, Soon Mi SHIM, Da Yeon LEE, Sang Ryun YIM, Eun Hye CHOI
  • Patent number: 10383904
    Abstract: The present invention relates to a composition which improves the quality of life of women by containing a ginseng berry extract as an active ingredient, and more specifically, to a composition which promotes the general psychological and physical health of women and improving the sexual function and sex life satisfaction women.
    Type: Grant
    Filed: April 2, 2014
    Date of Patent: August 20, 2019
    Assignee: Amorepacific Corporation
    Inventors: Chan Woong Park, Su Hwan Kim, Jeong Hwa Jang, Hyun Jung Shin, Sun Mi Kim, Wan Gi Kim, Sang Jun Lee
  • Publication number: 20190223486
    Abstract: The present invention relates to a catechin absorption enhancer in small intestinal epithelial cells, and more particularly, to an enhancer for improving an absorption rate of catechin in small intestinal cells and a composition including the same. The composition including the catechin absorption enhancer in the small intestinal epithelial cells according to the invention can enhance the absorption rate of catechin in the small intestinal epithelial cells, which leads to improved bioavailability. Therefore, the present invention can be expected to improve an antioxidant effect, an anti-aging effect, a lipolytic effect, and a variety of other effects of the catechin.
    Type: Application
    Filed: September 20, 2017
    Publication date: July 25, 2019
    Applicant: AMOREPACIFIC CORPORATION
    Inventors: Jin Oh CHUNG, Su Kyung KIM, Jeong Kee KIM, Wan Gi KIM, Song Seok SHIN, Soon Mi SHIM, Seon Bong LEE, Ji Hoon SONG, Seung Beom SEO
  • Patent number: 10342836
    Abstract: The present disclosure relates to a composition containing ginseng fruit extract. The present disclosure also relates to a composition for relieving premenstrual syndrome and menstrual pain, which contains ginseng fruit extract. The composition according to the present disclosure exhibits an effect of relieving or improving the symptoms of premenstrual syndrome and thus can be used as a pharmaceutical composition or a food composition.
    Type: Grant
    Filed: June 19, 2014
    Date of Patent: July 9, 2019
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Su Hwan Kim, Chan Woong Park, Jeong Hwa Jang, Wan Gi Kim, Sang Jun Lee
  • Patent number: 10022351
    Abstract: The present invention relates to a compound of Formula 1, and an SIRT 1 activator including, as an active ingredient, derivatives thereof or pharmaceutically acceptable salts thereof. The present invention also relates to a composition including the SIRT 1 activator for detoxification, for the improvement of metabolic disorders, for the prevention or improvement of eye diseases, or the prevention or improvement of immune diseases.
    Type: Grant
    Filed: May 20, 2016
    Date of Patent: July 17, 2018
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Byung Gyu Kim, Hyun Woo Jeong, Su Kyung Kim, Si Young Cho, Chan Woong Park, Dae Bang Seo, Wan Gi Kim, Sang Jun Lee
  • Patent number: 9999611
    Abstract: The present invention relates to a compound of Formula 1, and an SIRT 1 activator including, as an active ingredient, derivatives thereof or pharmaceutically acceptable salts thereof. The present invention also relates to a composition including the SIRT 1 activator for detoxification, for the improvement of metabolic disorders, for the prevention or improvement of eye diseases, or the prevention or improvement of immune diseases.
    Type: Grant
    Filed: May 20, 2016
    Date of Patent: June 19, 2018
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Byung Gyu Kim, Hyun Woo Jeong, Su Kyung Kim, Si Young Cho, Chan Woong Park, Dae Bang Seo, Wan Gi Kim, Sang Jun Lee
  • Patent number: 9913823
    Abstract: The present invention relates to a compound of Formula 1, and an SIRT 1 activator including, as an active ingredient, derivatives thereof or pharmaceutically acceptable salts thereof. The present invention also relates to a composition including the SIRT 1 activator for detoxification, for the improvement of metabolic disorders, for the prevention or improvement of eye diseases, or the prevention or improvement of immune diseases.
    Type: Grant
    Filed: October 18, 2012
    Date of Patent: March 13, 2018
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Byung Gyu Kim, Hyun Woo Jeong, Su Kyung Kim, Si Young Cho, Chan Woong Park, Dae Bang Seo, Wan Gi Kim, Sang Jun Lee
  • Publication number: 20180028584
    Abstract: The present specification relates to a composition for preventing, alleviating or treating burnout syndrome, containing a natural extract as an active ingredient. According to one aspect of the present invention, the composition contains a ginseng fruit extract, and thus is useful for preventing, treating and alleviating burnout syndrome. In addition, according to one aspect of the present invention, the composition further contains ginseng fruit and one or more selected from the group consisting of red ginseng, Angelica gigas, Cornus officinalis, Cervi parvum corni, and Nigella sativa, so as to maximize the synergistic effect among two or more ingredients, thereby exhibiting excellent effects on the prevention, treatment and alleviation of burnout syndrome. Therefore, there is an advantage of making individuals and society mentally and physically healthy since burnout syndrome can be prevented, treated and alleviated, by using the composition of the present invention.
    Type: Application
    Filed: February 5, 2016
    Publication date: February 1, 2018
    Inventors: Su-Hwan KIM, Chan-Woong PARK, Sun Mi KIM, Juewon KIM, Byung Gyu KIM, Wan Gi KIM, Sang Jun LEE
  • Patent number: 9795583
    Abstract: The present invention relates to a composition for preventing or treating heart disease, and more particularly, to a composition for preventing or treating heart disease, comprising (+)-syringaresinol. Specifically, (+)-syringaresinol as an active ingredient may exhibit excellent effect of preventing or improving heart disease by promoting SIRT1 expression and suppressing death of cardiomyocytes induced by reactive oxygen species. Accordingly, the composition according to the present disclosure may be used to prevent, improve or treat heart diseases including cardiovascular diseases.
    Type: Grant
    Filed: November 29, 2013
    Date of Patent: October 24, 2017
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Si Young Cho, Dae Bang Seo, Chan Woong Park, Wan Gi Kim, Sang Jun Lee
  • Publication number: 20160367614
    Abstract: The present specification relates to a composition which contains ginseng berry extract as an active ingredient. Further, the present specification relates to a composition which contains ginseng berry extract and alleviates premenstrual syndrome and menstrual pain. Further, in the present specification, the composition exhibits the effect of alleviating or improving the symptoms of premenstrual syndrome, and hence can be used as a pharmaceutical composition and food composition.
    Type: Application
    Filed: June 19, 2014
    Publication date: December 22, 2016
    Inventors: Su Hwan KIM, Chan Woong PARK, Jeong Hwa JANG, Wan Gi KIM, Sang Jun LEE
  • Patent number: 9452192
    Abstract: Disclosed is a composition for preventing or improving metabolic syndrome, including a tea plant leaf extract, a tea plant flower extract and a tea plant seed extract as active ingredients.
    Type: Grant
    Filed: December 20, 2012
    Date of Patent: September 27, 2016
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Su Kyung Kim, Hyun Jung Shin, Chan Su Rha, Seung Hun Kim, Bum Jin Lee, Young Kyung Kim, Dae Bang Seo, Wan Gi Kim, Jin Oh Chung, Sang Jun Lee
  • Publication number: 20160263079
    Abstract: The present invention relates to a compound of Formula 1, and an SIRT 1 activator including, as an active ingredient, derivatives thereof or pharmaceutically acceptable salts thereof. The present invention also relates to a composition including the SIRT 1 activator for detoxification, for the improvement of metabolic disorders, for the prevention or improvement of eye diseases, or the prevention or improvement of immune diseases.
    Type: Application
    Filed: May 20, 2016
    Publication date: September 15, 2016
    Inventors: Byung Gyu KIM, Hyun Woo JEONG, Su Kyung KIM, Si Young CHO, Chan Woong PARK, Dae Bang SEO, Wan Gi KIM, Sang Jun LEE
  • Publication number: 20160263077
    Abstract: The present invention relates to a compound of Formula 1, and an SIRT 1 activator including, as an active ingredient, derivatives thereof or pharmaceutically acceptable salts thereof. The present invention also relates to a composition including the SIRT 1 activator for detoxification, for the improvement of metabolic disorders, for the prevention or improvement of eye diseases, or the prevention or improvement of immune diseases.
    Type: Application
    Filed: May 20, 2016
    Publication date: September 15, 2016
    Inventors: Byung Gyu KIM, Hyun Woo JEONG, Su Kyung KIM, Si Young CHO, Chan Woong PARK, Dae Bang SEO, Wan Gi KIM, Sang Jun LEE
  • Publication number: 20160263078
    Abstract: The present invention relates to a compound of Formula 1, and an SIRT 1 activator including, as an active ingredient, derivatives thereof or pharmaceutically acceptable salts thereof. The present invention also relates to a composition including the SIRT 1 activator for detoxification, for the improvement of metabolic disorders, for the prevention or improvement of eye diseases, or the prevention or improvement of immune diseases.
    Type: Application
    Filed: May 20, 2016
    Publication date: September 15, 2016
    Inventors: Byung Gyu KIM, Hyun Woo JEONG, Su Kyung KIM, Si Young CHO, Chan Woong PARK, Dae Bang SEO, Wan Gi KIM, Sang Jun LEE
  • Publication number: 20160058811
    Abstract: The present invention relates to a composition which improves the quality of life of women by containing a ginseng berry extract as an active ingredient, and more specifically, to a composition which promotes the general psychological and physical health of women and improving the sexual function and sex life satisfaction women.
    Type: Application
    Filed: April 2, 2014
    Publication date: March 3, 2016
    Applicant: AMOREPACIFIC CORPORATION
    Inventors: Chan Woong PARK, Su Hwan KIM, Jeong Hwa JANG, Hyun Jung SHIN, Sun Mi KIM, Wan Gi KIM, Sang Jun LEE